Literature DB >> 23095033

Vascular binding of a pathogen under shear force through mechanistically distinct sequential interactions with host macromolecules.

Tara J Moriarty1, Meiqing Shi, Yi-Pin Lin, Rhodaba Ebady, Hong Zhou, Tanya Odisho, Pierre-Olivier Hardy, Aydan Salman-Dilgimen, Jing Wu, Eric H Weening, Jon T Skare, Paul Kubes, John Leong, George Chaconas.   

Abstract

Systemic dissemination of microbial pathogens permits microbes to spread from the initial site of infection to secondary target tissues and is responsible for most mortality due to bacterial infections. Dissemination is a critical stage of disease progression by the Lyme spirochaete, Borrelia burgdorferi. However, many mechanistic features of the process are not yet understood. A key step is adhesion of circulating microbes to vascular surfaces in the face of the shear forces present in flowing blood. Using real-time microscopic imaging of the Lyme spirochaete in living mice we previously identified the first bacterial protein (B. burgdorferi BBK32) shown to mediate vascular adhesion in vivo. Vascular adhesion is also dependent on host fibronectin (Fn) and glycosaminoglycans (GAGs). In the present study, we investigated the mechanisms of BBK32-dependent vascular adhesion in vivo. We determined that BBK32-Fn interactions (tethering) function as a molecular braking mechanism that permits the formation of more stable BBK32-GAG interactions (dragging) between circulating bacteria and vascular surfaces. Since BBK32-like proteins are expressed in a variety of pathogens we believe that the vascular adhesion mechanisms we have deciphered here may be critical for understanding the dissemination mechanisms of other bacterial pathogens.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095033      PMCID: PMC3508296          DOI: 10.1111/mmi.12045

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  60 in total

Review 1.  Fibronectin at a glance.

Authors:  Roumen Pankov; Kenneth M Yamada
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

2.  Electrotransformation of the spirochete Borrelia burgdorferi.

Authors:  D S Samuels
Journal:  Methods Mol Biol       Date:  1995

3.  Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-binding protein BBK32 is required for optimal infectivity.

Authors:  Jenny A Hyde; Eric H Weening; Mihee Chang; Jerome P Trzeciakowski; Magnus Höök; Jeffrey D Cirillo; Jon T Skare
Journal:  Mol Microbiol       Date:  2011-08-30       Impact factor: 3.501

4.  An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells.

Authors:  Woo-Yong Lee; Tara J Moriarty; Connie H Y Wong; Hong Zhou; Robert M Strieter; Nico van Rooijen; George Chaconas; Paul Kubes
Journal:  Nat Immunol       Date:  2010-03-14       Impact factor: 25.606

5.  Adaptation of the Lyme disease spirochaete to the mammalian host environment results in enhanced glycosaminoglycan and host cell binding.

Authors:  Nikhat Parveen; Melissa Caimano; Justin D Radolf; John M Leong
Journal:  Mol Microbiol       Date:  2003-03       Impact factor: 3.501

6.  Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis.

Authors:  Benjamin Andruski; Donna-Marie McCafferty; Teegan Ignacy; Brandie Millen; Jason J McDougall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

7.  Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes.

Authors:  Mahel Zeghouf; Joyce Li; Gareth Butland; Anna Borkowska; Veronica Canadien; Dawn Richards; Bryan Beattie; Andrew Emili; Jack F Greenblatt
Journal:  J Proteome Res       Date:  2004 May-Jun       Impact factor: 4.466

Review 8.  Epidemiology and clinical similarities of human spirochetal diseases.

Authors:  G P Schmid
Journal:  Rev Infect Dis       Date:  1989 Sep-Oct

9.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

10.  Essential role for OspA/B in the life cycle of the Lyme disease spirochete.

Authors:  Xiaofeng F Yang; Utpal Pal; Sophie M Alani; Erol Fikrig; Michael V Norgard
Journal:  J Exp Med       Date:  2004-02-23       Impact factor: 14.307

View more
  46 in total

1.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

2.  BB0744 Affects Tissue Tropism and Spatial Distribution of Borrelia burgdorferi.

Authors:  Beau Wager; Dana K Shaw; Ashley M Groshong; Jon S Blevins; Jon T Skare
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

3.  Borrelia burgdorferi RevA Significantly Affects Pathogenicity and Host Response in the Mouse Model of Lyme Disease.

Authors:  Rebecca Byram; Robert A Gaultney; Angela M Floden; Christopher Hellekson; Brandee L Stone; Amy Bowman; Brian Stevenson; Barbara J B Johnson; Catherine A Brissette
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

4.  Host cell heparan sulfate glycosaminoglycans are ligands for OspF-related proteins of the Lyme disease spirochete.

Authors:  Yi-Pin Lin; Rudra Bhowmick; Jenifer Coburn; John M Leong
Journal:  Cell Microbiol       Date:  2015-05-13       Impact factor: 3.715

5.  Pulling the trigger on lyme arthritis.

Authors:  Justin D Radolf
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

Review 6.  Spirochetal motility and chemotaxis in the natural enzootic cycle and development of Lyme disease.

Authors:  Md A Motaleb; Jun Liu; R Mark Wooten
Journal:  Curr Opin Microbiol       Date:  2015-11-02       Impact factor: 7.934

7.  Identification of lysine residues in the Borrelia burgdorferi DbpA adhesin required for murine infection.

Authors:  Danielle E Fortune; Yi-Pin Lin; Ranjit K Deka; Ashley M Groshong; Brendan P Moore; Kayla E Hagman; John M Leong; Diana R Tomchick; Jon S Blevins
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

Review 8.  Evolutionary aspects of emerging Lyme disease in Canada.

Authors:  N H Ogden; E J Feil; P A Leighton; L R Lindsay; G Margos; S Mechai; P Michel; T J Moriarty
Journal:  Appl Environ Microbiol       Date:  2015-08-21       Impact factor: 4.792

9.  Glycosaminoglycan binding by Borrelia burgdorferi adhesin BBK32 specifically and uniquely promotes joint colonization.

Authors:  Yi-Pin Lin; Qiang Chen; Jennifer A Ritchie; Nicholas P Dufour; Joshua R Fischer; Jenifer Coburn; John M Leong
Journal:  Cell Microbiol       Date:  2015-01-24       Impact factor: 3.715

Review 10.  Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.

Authors:  Yi-Pin Lin; Lingyun Li; Fuming Zhang; Robert J Linhardt
Journal:  Microbiology       Date:  2017-11-08       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.